Congratulations to Dr. Andrew Saxon of the NIDA CTN’s Pacific Northwest Node!

ADAI wants to issue a hearty CONGRATULATIONS to Andrew Saxon, MD, the recipient of the 2025 Outstanding Achievement and Service Award from the American Academy of Addiction Psychiatry (AAAP).

[Dr. Saxon is a long-time member of the NIDA Clinical Trials Network’s Pacific Northwest Node, located at ADAI and has been working with many of our staff and faculty for decades on various research projects.]

This honor is presented to an outstanding member of the community who works in the field of addiction and who has contributed significantly to the science, teaching, treatment, and/or advocacy related to substance use disorders and co-occurring mental illness.

Before his entry into psychiatry, Dr. Saxon completed an internal medicine internship and worked for four years as an emergency room physician. Following a general psychiatry residency at UW, Dr. Saxon has more than four decades of experience as a clinical and research addiction psychiatrist. He sits on the editorial boards of the journals, Drug and Alcohol Dependence and General Hospital Psychiatry. He is a lifetime Distinguished Fellow of the American Psychiatric Association, where he served as the chair of the Council on Addiction Psychiatry from 2017-2019. He’s a fellow of the American Society of Addiction Medicine, as well as a member of College on Problems of Drug Dependence and of the American Academy of Addiction Psychiatry. He has given numerous presentations at conferences and has more than 200 papers published in peer reviewed journals.

Congratulations, Dr. Saxon, and thank you for your many years of partnership and support of ADAI and the CTN!